Literature DB >> 28914332

[Comment on: ketamine for prevention of postoperative delirium and pain].

S Ziemann1, M Coburn2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28914332     DOI： 10.1007/s00101-017-0364-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  5 in total

Review 1.  [Anesthesiological management of elderly trauma patients].

Authors:  M Coburn; A B Röhl; M Knobe; A Stevanovic; C Stoppe; R Rossaint
Journal:  Anaesthesist       Date:  2016-02       Impact factor: 1.041

Review 2.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

3.  Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass.

Authors:  Judith A Hudetz; Kathleen M Patterson; Zafar Iqbal; Sweeta D Gandhi; Alison J Byrne; Anthony G Hudetz; David C Warltier; Paul S Pagel
Journal:  J Cardiothorac Vasc Anesth       Date:  2009-02-23       Impact factor: 2.628

Review 4.  Postoperative cognitive dysfunction: Incidence and prophylaxis.

Authors:  M Coburn; A Fahlenkamp; N Zoremba; G Schaelte
Journal:  Anaesthesist       Date:  2010-02       Impact factor: 1.041

Review 5.  European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium.

Authors:  César Aldecoa; Gabriella Bettelli; Federico Bilotta; Robert D Sanders; Riccardo Audisio; Anastasia Borozdina; Antonio Cherubini; Christina Jones; Henrik Kehlet; Alasdair MacLullich; Finn Radtke; Florian Riese; Arjen J C Slooter; Francis Veyckemans; Sylvia Kramer; Bruno Neuner; Bjoern Weiss; Claudia D Spies
Journal:  Eur J Anaesthesiol       Date:  2017-04       Impact factor: 4.330
  5 in total
  1 in total

1.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.